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The Onecut (OC) transcription factor HNF-6 (OC-1) is required during embryogenesis for pancreatic specification, morphogenesis and
endocrine differentiation. In mammals, HNF-6 has two paralogs, OC-2 and OC-3, which share DNA-binding and transcriptional activation
properties and have expression patterns that overlap with that of HNF-6. This suggested that OC-2 and OC-3 play redundant roles with HNF-6 in
pancreas development. Here, we have addressed this hypothesis by analyzing the phenotype of mice knockout for the Onecut factors. We found
that neither OC-2 nor OC-3 is required for pancreas specification. However, OC-2 plays partially redundant roles with HNF-6 in pancreas
morphogenesis and in the differentiation of endocrine precursors. As similar molecular events drive endocrine differentiation in the pancreas and
gastrointestinal tract, we also investigated if Onecut factors are involved in enteroendocrine differentiation. OC-2 and OC-3 were found to
delineate specific antero-posterior regions of the gut around embryonic day 12.5. Later on, OC2 was expressed in several gut cell types, whereas
OC-3 behaved as a specific marker of the enteroendocrine lineage. However, OC-2 and OC-3, alone or in combination, were dispensable for gut
development and enteroendocrine differentiation. In conclusion, our data reveal partially redundant roles for HNF-6 and OC-2 in developing
pancreas and identify new markers for antero-posterior patterning of the gut and for enteroendocrine differentiation.
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Pancreas development is initiated around embryonic day (e)
8.5 in the mouse, by the specification of a dorsal region and a
ventral region of the foregut endoderm to a pancreatic fate. At
e10.5, these regions form buds which contain pancreatic
progenitor cells, and at e14.5 the ventral and dorsal pancreas
fuse together to form a single organ. Meanwhile, the progenitors
undergo a multistep differentiation process, which results in the
production of exocrine, ductal, and endocrine cells (reviewed in
Edlund, 2002; Jensen, 2004).
Studies on knockout mice have identified transcriptions
factors that are involved in pancreas formation (reviewed in⁎ Corresponding author. Fax: +32 2 7647507.
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doi:10.1016/j.ydbio.2007.02.027Wilson et al., 2003; Servitja and Ferrer, 2004; Habener et al.,
2005; Collombat et al., 2006). Among them, Pdx-1 is expressed
in the foregut endoderm starting at e8.5 when pancreas
development is initiated. Pdx1 gene inactivation in mice and
humans results in pancreas agenesis (Jonsson et al., 1994;
Ahlgren et al., 1996; Offield et al., 1996; Stoffers et al., 1997).
Overexpression of Pdx-1 in chicken induces pancreas budding
and initiates pancreatic differentiation (Grapin-Botton et al.,
2001), and a combination of XlHbox8, the Xenopus homolog of
Pdx-1, with the transcription factor Ptf1a/p48 is sufficient to
commit endodermal cells to pancreatic differentiation (Afelik
et al., 2006). These studies have led to the conclusion that Pdx-
1 controls pancreas specification. The transcription factor Ngn3
is another key regulator of pancreas development as it is
expressed in pancreatic endocrine precursor cells and is
required for specification of the pancreatic endocrine cell
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(Gradwohl et al., 2000), whereas overexpression of Ngn3 in the
pancreas leads to premature differentiation of the progenitor
cells into endocrine cells (Apelqvist et al., 1999; Schwitzgebel
et al., 2000). Studies on ngn3−/− embryos have demonstrated
that Ngn3 is also important for specification of the enteroendo-
crine cells in the stomach and intestine (Jenny et al., 2002; Lee
et al., 2002; reviewed in Lee and Kaestner, 2004; Schonhoff
et al., 2004).
Because of the central role of Pdx-1 and Ngn3 in pancreas
development, it is important to characterize regulators of their
expression. We have identified one of them, called HNF-6 (or
OC-1; Lemaigre et al., 1996), which is the prototype of the
Onecut (OC) family of transcription factors (Lannoy et al.,
1998). HNF-6 is required for timely initiation of Pdx-1
expression in the endoderm (Jacquemin et al., 2003a) and it
maintains Ngn3 expression in pancreatic endocrine precursors
(Jacquemin et al., 2000; Maestro et al., 2003). Indeed, Pdx-1
fails to appear at e8.5 in the endoderm of hnf6−/− embryos, but
becomes expressed at e9.0, and this results in the development
of a hypoplastic pancreas. Also, in developing hnf6−/−
pancreas, Ngn3 expression is initiated normally but then
becomes inhibited around e12.5, resulting in deficient endo-
crine development.
The HNF-6 paralogs OC-2 (Jacquemin et al., 1999, 2003b)
and OC-3 (Vanhorenbeeck et al., 2002) share with HNF-6
similar DNA-binding properties and transcriptional activation
domains. In liver, HNF-6 and OC-2 have redundant roles in the
differentiation of hepatocytes and biliary cells (Clotman et al.,
2005). Therefore, redundancy among the Onecut factors in
other organs in which they are co-expressed is likely. The
expression of the three Onecut factors is initiated in the
endoderm in the order Hnf6 → Oc2 → Oc3, and becomes
detectable at the 5-, 9- and 14-somite stages, respectively
(Pierreux et al., 2004). HNF-6 is expressed in the pancreatic
progenitor cells, and later becomes restricted to ductal cells
(Pierreux et al., 2006). Oc2 expression in the pancreas is high
until e12.5, then it decreases until e16.5, after which its levels
significantly re-increase (Jacquemin et al., 2003b, Fig. S1). Oc3
expression is detected in the pancreas until e12.5 but not at later
stages. Finally, we also detect Oc2 and Oc3 expression in the
intestine and the stomach during embryogenesis, whereas HNF-
6 is not expressed in these organs (Pierreux et al., 2004;
Vanhorenbeeck et al., 2002).
The overlapping transcriptional properties of the Onecut
factors and their overlapping expression patterns in the pancreas
suggested that OC-2 and OC-3 play a role in pancreas
development and in pancreatic endocrine differentiation, and
that these roles may, at least partially, be redundant with those of
HNF-6. Furthermore, as enteroendocrine differentiation criti-
cally depends on Ngn3 (Jenny et al., 2002; Lee et al., 2002), we
postulated that Ngn3 expression in the gut depends on a Onecut
factor, like it does in the pancreas. To address the role of OC-2
and OC-3 in pancreas development and in enteroendocrine
differentiation, we have studied OC-2 and OC-3 knockout mice.
Our results show that the Onecut factors are dispensable for
enteroendocrine differentiation, but that HNF-6 and OC-2 haveredundant functions in pancreatic morphogenesis and endocrine
differentiation.
Materials and methods
Construction of targeting vectors and generation of knockout mice
The targeting construct for generating the oc3−/− mice was made by
subcloning oc3 fragments from the female mouse 129 RPCI-21 PAC Library
(Roswell Park Cancer Institute) in the pL2EGFPpAL(−) vector (gifts from D.
Metzger). R1 embryonic stem (ES) cells (gift from A. Nagy) were electroporated
with the linearized construct and were selected with neomycin. Recombinant ES
clones containing the inactivated oc3 allele were selected by polymerase chain
reaction (PCR), Southern blotting and karyotype screening. ES cells were
aggregated with morula-stage embryos and the resulting blastocysts were
transferred into pseudopregnant mice. Chimeric males were test bred with Swiss
mice for germ line transmission. Heterozygous offspring was intercrossed to
generate knockout progeny. The mice were genotyped by PCR. Primers for the
OC-3 genotyping were: mOC-31, 5′-GCTGAAGCGCTACAGCATC-3′, mOC-
32, 5′-GCGCAGCGCCGACATGCG-3′, GFP-1, 5′-CCTCGTGACCACCCT-
GAC-3′ and GFP-2, 5′-CTCAGGTAGTGGTTGTCGG-3′.
Hnf6−/− and oc2−/− mice have been described (Clotman et al., 2005;
Jacquemin et al., 2000). The animals were raised in our animal facility and
treated according to the principles of laboratory animal care of the University
Animal Welfare Committee.
Immunohistochemistry and immunofluorescence
Embryos were fixed overnight at 4 °C in 4% paraformaldehyde in phosphate-
buffered saline (PBS), and were either frozen in gelatin/sucrose solution or
embedded in paraffin prior to sectioning at 10 or 5 μm. Primary antibodies were
as follows: rat anti-OC-2 (Clotman et al., 2005), guinea pig anti-OC-3 (Pierreux
et al., 2004), rabbit anti-Pdx-1 (gift form C. Wright), rabbit anti-Ngn3 (gift from
M. German), rabbit anti-chromogranin A (Diasorin), rabbit anti-serotonin
(Diasorin), rabbit anti-CCK/gastrin (gift fromC. Roche), rabbit anti-somatostatin
(Dako), rabbit anti-ghrelin (gift from C. Tomasetto), rabbit anti-PYY, rabbit anti-
GIP, rabbit anti-secretin, rabbit anti-GLP-1 and rabbit anti-neurotensin (Phoenix
Pharmaceuticals). Primary antibodies were detected by immunofluorescence (IF)
using secondary antibodies coupled to AlexaFluor 594 (Molecular Probes) or
biotinylated immunoglobulin G and streptavidin–AlexaFluor 488 conjugate
(Molecular Probes). For immunohistochemistry (IHC), primary antibodies were
detected by immunoperoxidase activity using biotinylated sheep or goat anti-
rabbit, sheep anti-rat or sheep anti-guinea pig immunoglobulin G (Jackson
ImmunoResearch), a streptavidin–peroxidase conjugate and DAB+ (Dako).
Whole-mount immunohistochemistry
Whole-mount IHC was performed as described (Ohlsson et al., 1993).
Embryos or dissected gastrointestinal tracts were fixed at 4 °C in 4%
paraformaldehyde in PBS. Endogenous peroxidase activity was blocked by
immersing the embryos for 1 h in methanol containing 3% hydrogen peroxide.
Primary antibodies (Pdx-1 antibodies were from H. Edlund and C. Wright) were
detected with the Vectastain Elite ABC kit and DAB (Vector). After each
antibody incubation, tissues were washed for 5 h in TBST (50 mM Tris–HCl,
pH 7.5, 150 mM NaCl, 0.1% Triton X-100) with five buffer changes.
Transfections and electrophoretic mobility shift assays (EMSA)
Rat-1 fibroblasts were transfected by lipofection using Lipofectamine 2000
(Invitrogen), as previously described (Jacquemin et al., 2003a). Briefly, 200 ng
of p3957ngn3-luc reporter vector coding for firefly luciferase (Jacquemin et al.,
2000), 150 ng of pCMVFlag–OC2 or pCMVFlag–HNF-6 expression vector,
and 30 ng of pRL138 (Lemaigre et al., 1996) coding for Renilla luciferase as
internal control, were used. Luciferase activities were expressed as the ratio of
reporter activity (firefly luciferase) to internal control (Renilla luciferase).
EMSAwere performed as previously described, using extracts of transfected
3T3 cells (Jacquemin et al., 2000).
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Generation of oc3 knockout mice
To explore the role of the Onecut factors in development, we
generated mice homozygous for a null deletion in the
corresponding oc gene by homologous recombination in
mouse ES cells. The generation of hnf6−/− and oc2−/− mice
has been described (Jacquemin et al., 2000; Clotman et al.,
2005). To generate the oc3−/− mice, the first exon of the oc3
gene, which codes for a region of the protein essential for DNA-
binding activity (Lannoy et al., 1998), was replaced by a
sequence coding for the enhanced green fluorescence protein
(Figs. 1A–D). Recombinant ES clones were identified by PCR
screening and Southern blot analysis using probes located both
5′ and 3′ from the recombinant site and in the selection gene
(Figs. 1B–D and data not shown). Germ line chimeras and
heterozygous mice were obtained. Crossbreeding of the
heterozygous animals produced oc3−/− mice with the expected
mendelian frequency at birth. These mice were viable and
fertile, and were indistinguishable from wild type animals in
appearance, average weight and behavior. IHC experiments
performed with OC-3 antibodies on oc3−/− tissue sections
revealed an absence of staining in tissues where OC-3
expression is normally observed, confirming that the inactivated
oc3 allele is a null allele (data not shown).
Role of Onecut factors in pancreas morphogenesis
We have previously shown that the pancreas is hypoplastic in
hnf6−/− embryos and that this results from delayed pancreaticFig. 1. Targeted disruption of the oc3 gene. (A) Scheme of the oc3 gene, targeting con
fluorescence protein and neomycin resistance coding sequences. The first exon conta
blot analysis of DNA isolated from three ES clones (lanes 1–3) electroporated with t
was confirmed by amplification of a 3.5-kb fragment with the primers (arrows in
confirmed by hybridization of SpeI-digested DNAwith the 5′ probe. SpeI-digestion g
fragment for the mutated allele. (D) No additional insertion was detected by hybridiz
9.2-kb fragment for the mutated allele.specification of the endoderm, as evidenced by delayed
expression of the Pdx1 gene (Jacquemin et al., 2003a,b). To
investigate the roles of OC-2 and OC-3 in pancreas
organogenesis, we performed whole-mount IHC experiments
with a Pdx-1 antibody at different developmental stages in
oc2−/− and oc3−/− embryos, and compared the results with
those from control and hnf6−/− embryos. Around e10.5 (31- to
39-somite stages), the ventral pancreatic bud was missing and
the dorsal pancreas was smaller in hnf6−/− embryos as
compared to control embryos (Figs. 2A–B). In contrast, the
dorsal and ventral pancreatic buds appeared to be normal in
oc2−/− (Fig. 2C) and oc3−/− (Fig. 2D) embryos. Similar
experiments performed at e14.5 and at the adult stage
revealed no difference between control, oc2−/− and oc3−/−
pancreas (data not shown). Thus, contrary to HNF-6, OC-2 and
OC-3 are dispensable for pancreas organogenesis.
To investigate if Onecut factors play redundant roles in
pancreas organogenesis, we generated all possible combina-
tions of double Onecut knockout embryos. The different double
knockout embryos died at birth, and the analysis was focused
on prenatal development. By whole-mount IHC experiments
with a Pdx-1 antibody at e10.5, we found that pancreas
organogenesis proceeded normally in oc2−/−;oc3−/− embryos
(Fig. 2F). Early pancreas development was not more affected in
hnf6−/−;oc2−/− (Fig. 2E) or in hnf6−/−;oc3−/− (Fig. 2G)
embryos than in single hnf6−/− embryos (Fig. 2B). These
results indicated that OC-2 and OC-3 do not play redundant
roles with HNF-6 at the onset of pancreas organogenesis.
To study if OC-2 or OC-3 could act redundantly with HNF-6
at later stages of pancreas organogenesis, we performed whole-
mount IHC experiments on double knockout embryos fromstruct and product of homologous recombination. GFP and neo refer to the green
ins the cut domain which is critical for DNA binding. (B–D) PCR and Southern
he oc3 targeting construct. (B) Correct homologous recombination at the 3′ end
panels A) indicated. (C) Correct homologous recombination at the 5′ end was
enerated a 13.7-kb fragment for wild-type genomic DNA (gDNA) and a 6.4-kb
ation of EcoRI-digested DNAwith the neo probe. EcoRI-digestion generated a
Fig. 2. Onecut factors have no redundant role in early pancreas development. (A–G) Whole-mount IHC experiments with a Pdx-1 antibody were performed on e10.5
embryos. The dorsal and ventral pancreatic buds were observed in control (A), oc2−/− (C), oc3−/− (D) and oc2−/−;oc3−/− (F) embryos. Only the dorsal pancreatic
bud was found in hnf6−/− (B), hnf6−/−;oc2−/− (E) and hnf6−/−;oc3−/− (G) embryos. The reduced size of the dorsal and ventral buds in the oc3−/− embryo results
from the earlier developmental stage of this embryo (31-somite stage versus 37-somite stage). Bar: 300 μm.
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in oc2−/−;oc3−/− embryos and pancreas hypoplasia was not
more severe in hnf6−/−;oc3−/− embryos than in hnf6−/−
embryos (data not shown), indicating that OC-3 is not
redundant with other Onecut factors in pancreas organogenesis.
In contrast, pancreas organogenesis was more affected when
both the hnf6 and oc2 genes were inactivated, as compared to
single hnf6−/− knockout embryos. At e13.5, in hnf6−/−
embryos (Fig. 3B), the pancreatic buds had not fused, the dorsal
pancreas was smaller than in controls (Fig. 3A), and the ventral
pancreas was restricted to a minute bud in the duodenal loop. InFig. 3. Redundant role of HNF-6 and OC-2 in ventral pancreas morphogenesis.
(A–D) Whole-mount IHC experiments with a Pdx-1 antibody were performed
on e13.5 embryos. The control embryos have a pancreas formed by the fusion of
its dorsal and ventral components (A). The hnf6−/− embryos have a hypoplastic
dorsal pancreas and the ventral pancreas consists in a small bud (arrow) located
on the duodenum (B). The dorsal pancreas of hnf6−/−;oc2−/− embryos is more
hypoplastic than in hnf6−/− embryos (C), and the ventral pancreas consists of
two cell clusters on the inner side of the duodenal loop (D). Arrows in panels C
and D point to these cell clusters. In panel D, side view, the duodenal part seen in
panel C was separated from the stomach to allow visualization of the two cell
clusters. d, duodenum; s, stomach. Bar: 500 μm.hnf6−/−;oc2−/− embryos, the dorsal pancreas was smaller than
in hnf6−/− embryos and no ventral bud was observed (Fig. 3C).
Instead, the ventral pancreas consisted of two very small cell
clusters on the duodenum (arrows in Figs. 3C and D). We
concluded that HNF-6 and OC-2 exert partially redundant
functions in dorsal and ventral pancreas organogenesis.
Role of Onecut factors in pancreatic endocrine differentiation
The hnf6−/− embryos have deficient expression of Ngn3 and
defective endocrine differentiation. To test the role of OC-2 and
OC-3 in pancreatic endocrine differentiation, we performed
IHC experiments with a Ngn3 antibody on e14.5 embryos, i.e.
when Ngn3 expression peaks in normal developing pancreas.
We also performed IHC experiments with insulin and glucagon
antibodies on pancreas sections at e18.5. The results showed
that expression of Ngn3, insulin and glucagon in oc2−/− (Fig.
4C), oc3−/− (Fig. 4D) and oc2−/−;oc3−/− (Fig. 4F) embryos
was indistinguishable from that of control embryos (Fig. 4A and
data not shown). We concluded that OC-2 and OC-3 are
dispensable for pancreatic endocrine differentiation.
To test a possible redundancy between HNF-6 and OC-2 or
between HNF-6 and OC-3 in pancreatic endocrine differentia-
tion, we analyzed Ngn3 expression on pancreas sections of
double knockout embryos at e14.5. The reduction in the
number of Ngn3-expressing cells in hnf6−/−;oc3−/− pancreas
(Fig. 4G) was not greater than that in hnf6−/− pancreas (Fig.
4B). In contrast, endocrine differentiation was more affected in
hnf6−/−;oc2−/− embryos than in hnf6−/− embryos. Indeed,
pancreas sections of double knockouts were nearly devoid of
Ngn3-expressing cells (Fig. 4E). Quantification of the number
of Ngn3-expressing cells showed that an average of 56, 4, 3 and
0.5 Ngn3+ cells per section were found respectively in control,
hnf6−/−, hnf6−/−;oc3−/− and hnf6−/−;oc2−/− embryos (4 to
13 sections counted per embryo). Analysis of insulin and
glucagon expression at e18.5 revealed few insulin- and
glucagon-expressing cells in hnf6−/− pancreas (Figs. 4I and
Fig. 4. HNF-6 and OC-2 play partially redundant roles in pancreatic endocrine differentiation. (A–P) IHC experiments performed with a Ngn3 antibody on e14.5
pancreatic sections (A–G), on e18.5 pancreatic sections with an insulin (H, I, L) or a glucagon (J, K, M) antibody, and on e10.5 sections of the dorsal pancreatic buds
with a Pax6 antibody (N, P). (A–G) Ngn3-positive cells were found in control (A), oc2−/− (C), oc3−/− (D) and oc2−/−;oc3−/− (F) pancreas. Few Ngn3 precursors
were found on the hnf6−/− (B) and hnf6−/−;oc3−/− (G) pancreas sections, whereas a single Ngn3-expressing cell (arrow) was present on some hnf6−/−;oc2−/− (E)
pancreas sections. Bar: 250 μm. (H–M) In control pancreas, insulin and glucagon cells were incorporated in developing islets of Langerhans (H, J). Islets of
Langerhans were absent from hnf6−/− pancreas and isolated insulin and glucagon cells were found associated with pancreatic ducts (I, K). No insulin or glucagon cells
were found in the majority of the sections in hnf6−/−;oc2−/− pancreas (L, M). Bar: 300 μm. (N–P) Similar numbers of differentiating endocrine cells were found in
control (N), in hnf6−/− (O) and in hnf6−/−;oc2−/− (P) embryos. Bar: 200 μm.
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sections (Figs. 4L and M), or detected occasionally on a few
sections (data not shown).
In hnf6−/− embryos, pancreatic endocrine differentiation
becomes defective around e12.5. However it is initiated at the
proper time around e9.5 (Jacquemin et al., 2000). This was
also the case in hnf6−/−;oc2−/− embryos. Indeed, expression
of the endocrine marker Pax6 at e10.5 in hnf6−/−;oc2−/−
embryos (Fig. 4P) was indistinguishable from that of control
(Fig. 4N) and hnf6−/− embryos (Fig. 4O; Jacquemin et al.,
2000).
Taken together, these results indicated that HNF-6 and OC-2
are not required to initiate endocrine differentiation, but do play
redundant roles at a subsequent step of pancreatic endocrine
differentiation.
OC-2 controls the ngn3 gene promoter
Our previous data suggest that HNF-6 controls the ngn3
promoter. HNF-6 can bind to a proximal site and a distal site,
which are respectively located 453 bp and 3187 bp upstreamof the TATA box (Jacquemin et al., 2000). To study if OC-2 is
also able to bind to these sites, we performed EMSA using
extracts from cells transfected with an OC-2 expression vector.
Extracts from cells transfected with an empty expression
vector, and which are devoid of OC-2, served as negative
control. A protein/DNA complex was observed when the
probes corresponding to the proximal and distal sites were
incubated with OC-2-containing cell extracts (Fig. 5A).
Similarly to what it is seen with HNF-6 (Jacquemin et al.,
2000), the proximal site binds OC-2 with lower affinity than
the distal one.
To test if OC-2 can transactivate the ngn3 gene promoter, a
3957-bp-long ngn3 gene fragment containing the two HNF-6/
OC-2 sites cloned upstream of the luciferase gene were
cotransfected in Rat-1 cells with an OC-2 expression vector
(Fig. 5B). The results showed that the presence of OC-2
increases by 2.25-fold the activity of the ngn3 promoter. This
stimulation is similar to the stimulation obtained with HNF-6 in
parallel experiments (Fig. 5B). We concluded from this set of
experiments that OC-2 can bind to the ngn3 promoter and
stimulate its activity.
Fig. 5. The ngn3 promoter is controlled by OC-2. (A) EMSA performed with
extracts from cells transfected with an OC-2 expression vector (+) or with an
empty vector (−). The radioactive probes used are two sites of the ngn3
promoter which were previously shown to bind HNF-6. A retarded band was
observed both on the proximal (prox.) and on the distal (dist.) sites in the
presence of extracts containing OC-2. (B) Transient transfection of Rat-1 with a
firefly luciferase reporter plasmid driven by 3957 bp of ngn3 promoter sequence
and an internal control plasmid coding for Renilla luciferase, in the presence of
empty (−), HNF-6 or OC-2 expression vectors (mean±standard error of the
mean, n=6).
Fig. 6. OC-3 and OC-2 are differentially expressed in the gastrointestinal tract
during development. (A–B) Summary of OC-3 (A) and OC-2 (B) expression at
two stages of development of the gastrointestinal tract (e12.5 and e18.5).
Transversal sections of the duodenum corresponding to the two-headed arrows
are illustrated in the lower four panels. (C–H) IF experiments were performed on
e18.5 duodenal sections with the antibodies indicated. (C) OC-2 and OC-3 are
co-expressed in some cells of the duodenum. Bar: 250 μm. (D, G) OC-3 and
Ngn3 are not co-expressed whereas low levels of OC-2 are observed in Ngn3-
expressing cells (white arrows). (E, F, H) Co-expression of OC-3 with ChromoA
(E) or secretin (F), and of OC-2 with ChromoA (H) indicates that the two factors
are found in differentiated enteroendocrine cells. Bar: 100 μm. s, stomach; rd,
rostral duodenum; cd, caudal duodenum; j, jejunum; p, pylorus; cbd, common
bile duct; c, crypt; v, villus.
690 V. Vanhorenbeeck et al. / Developmental Biology 305 (2007) 685–694OC-2 and OC-3 show distinct and dynamic spatio-temporal
expression patterns in the gastrointestinal tract during
development
In view of the role of Onecut factors in expression of Ngn3 in
the pancreas and of the role of Ngn3 in enteroendocrine
differentiation, we next studied whether OC-2 and OC-3 could
control enteroendocrine differentiation. Previous RT–PCR data
indicated that OC-2 and OC-3 are expressed in the stomach and
in the intestine (Vanhorenbeeck et al., 2002; Pierreux et al.,
2004) but the cell types expressing these factors are unknown.
Thus, we first characterized by IHC the expression patterns of
OC-2 and OC-3 in the gastrointestinal tract starting at e12.5, the
stage at which enteroendocrine differentiation is initiated by the
expression of Ngn3 (Jenny et al., 2002).
At e12.5, OC-3 expression was found in the gut epithelium
from the antral stomach to the region of the duodenum that
connects with the common bile duct (Fig. 6A and Fig. S2). At
the same stage, OC-2 was present in a gut region located
caudally from the OC-3-expressing region. Indeed, OC-2 was
detectable in the epithelium of the caudal duodenum and of the
jejunum (Fig. 6B and Fig. S2). At e18.5, OC-3 expressionbecame restricted to cells scattered in the intestinal epithelium
(Fig. 6A and Fig. S2), whereas the expression domain of OC-2
expanded rostrally. OC-2 was found in the pylorus, the antrum
of the stomach and in the epithelium of the villi. Lower ex-
Fig. 7. OC-3 is expressed in the enteroendocrine lineage and Onecut factors are
dispensable for enteroendocrine development. (A–H) IHC experiments on
duodenal sections of control (A, C, E), ngn3−/− (B), oc3−/− (D, G), oc2−/−
(F), or oc2−/−;oc3−/− (H) embryos were performed with the antibodies
indicated. In contrast to control embryos (A), OC-3-expressing cells are lacking
in e18.5 ngn3−/− embryos (B). The expression of Ngn3− at e14.5 and of
ChromoA at e18.5 is similar in control (C, E) and in oc2−/−, oc3−/− or oc2−/−;
oc3−/− embryos (D, F, G, H). Bar: 300 μm. (I–J) IHC experiments performed
on duodenal sections of e18.5 control show that GIP is expressed at similar
levels in control (I) and oc2−/−;oc3−/− (J) embryos. Bar: 150 μm.
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and Fig. S2). From this stage on, we found that the few OC-3-
expressing cells of the intestinal epithelium also expressed
OC-2 (Fig. 6C).
From the expression profiles of OC-2 and OC-3, summar-
ized in Figs. 6A–B, we concluded that these factors are markers
of distinct specific domains of the gastrointestinal tract during
development.
The pattern of OC-3 expression described above was
compatible with a role for this factor in enteroendocrine
differentiation. Indeed, at e12.5 (data not shown) and e14.5,
Ngn3 and OC-3 were both found in the rostral duodenum (Fig.
S2). However, at e18.5, co-expression of OC-3 and Ngn3 was
no longer observed (Fig. 6D). Typically, Ngn3 cells were
localized at the bottom of the crypts, as described in the adult
intestine (Jenny et al., 2002), whereas OC-3 cells were found
from the crypts up to the villi. This scattered distribution
resembles that of the differentiated enteroendocrine cells. To
verify if OC-3 was expressed in differentiated enteroendocrine
cells, we looked for co-expression of OC-3 with the endocrine
cell marker chromogranin A (ChromoA). We found cells that
express either OC-3 or ChromoA or both (Fig. 6E). The latter,
which represented about a half of the OC-3-positive cells,
corresponded to differentiated enteroendocrine cells. This raised
the question as to whether OC-3 is expressed in all or only some
enteroendocrine cell types. Double IF with OC-3 antibody and
antibodies directed against the different enteroendocrine
hormones (same hormones as those tested in Fig. S3) showed
that OC-3 is present in all the enteroendocrine cell types
examined, as illustrated for secretin in Fig. 6F.
As half of the OC-3-expressing cells were differentiated
(ChromoA-positive) endocrine cells, it was likely that Chro-
moA-negative OC-3-positive cells corresponded to cells
committed to the enteroendocrine lineage, but not yet fully
differentiated. This hypothesis was supported by the analysis of
ngn3−/− embryos, which lack endocrine cells in the intestine.
IHC experiments performed on duodenal sections at e18.5
showed no OC-3-expressing cells in ngn3−/− embryos (Fig.
7B), whereas they were detectable in control embryos (Fig. 7A).
This suggested that OC-3-expressing cells at the end of
gestation belong to the enteroendocrine lineage.
As indicated above, expression of OC-2 was found in most
epithelial cells of the villi. However, at e18.5, OC-2 was
detectable in Ngn3-expressing cells (Fig. 6G), and was found in
most of the differentiated ChromoA-expressing enteroendo-
crine cells (Fig. 6H). This indicated that OC-2 is expressed in
enteroendocrine cells but does not qualify as an enteroendo-
crine-specific marker.
Oc2 and oc3 knockout mice have no enteroendocrine
differentiation defect
We examined gastrointestinal development following inacti-
vation of the oc2 or oc3 genes. Gastrointestinal tracts of oc2−/−
or oc3−/− embryos dissected at various developmental stages
showed no abnormalities. Analysis by hematoxylin/eosin or
Masson's trichrome staining on sections of oc2−/− or oc3−/−newborns did not reveal histological defects (data not shown).
The pyloric region was normal, Brunner's glands were present
in the duodenum, and the crypt/villus architecture in the small
intestine was not altered.
The expression pattern of OC-3 at e12.5 and e14.5 suggested
a role for OC-3 in the initial stage of enteroendocrine
differentiation. To test this, we looked at Ngn3 expression in
control and oc3−/− embryos. At e14.5, Ngn3-positive cells
were similarly detected in the rostral duodenum of control (Fig.
7C) and oc3−/− (Fig. 7D) embryos, indicating that OC-3 is not
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progenitors.
Our co-expression data from e18.5 on pointed to a possible
role of OC-2 and OC-3 in the process of enteroendocrine
differentiation after the precursor stage. To address this
question, we performed IHC experiments with a ChromoA
antibody on oc2−/− and oc3−/− sections. At e18.5, Chro-
moA-positive cells were observed on control sections in the
villi all along the intestine (Fig. 7E), and a similar labeling was
observed on oc2−/− (Fig. 7F) or oc3−/− (Fig. 7G) sections,
suggesting that enteroendocrine cells can reach maturity in the
absence of OC-2 or of OC-3. Since OC-2 and OC-3 showed
an overlapping expression in the duodenum, these two factors
could have redundant roles. To test this possibility, we tested
the presence of ChromoA (Fig. 7H) in the intestine of oc2−/−;
oc3−/− embryos. No difference between control and oc2−/−;
oc3−/− sections was found.
These results did not exclude a role for OC-2 and/or OC-3 in
the differentiation process of one or several specific endocrine
cell type(s). Therefore, we performed IHC experiments with
antibodies against nine different hormones on e18.5 sections.
We found that each enteroendocrine cell type was present in
oc2−/−, oc3−/− and oc2−/−;oc3−/− tissues (Figs. 7I and J,
Fig. S3 and data not shown), indicating that enteroendocrine
differentiation proceeds normally in the absence of OC-2 and
OC-3.
Finally, HNF-6, which is no longer expressed after e12.5 in
the gastrointestinal tract of wild-type embryos, was not
ectopically expressed in the knockout embryos (data not
shown). This ruled out the possibility that HNF-6 compensates
for the absence of OC-2 or OC-3. We concluded that OC-2 and
OC-3 have no obvious role in enteroendocrine differentiation.
Discussion
Our previous work on the Onecut transcription factor HNF-
6 showed that it is essential for pancreas morphogenesis and
for pancreatic endocrine differentiation (Jacquemin et al.,
2000, 2003a). The overlapping transcriptional properties and
expression patterns of Onecut factors suggested that the HNF-
6 paralogs OC-2 and OC-3 play a role in pancreas
development. Here, we have tested this hypothesis by
analyzing pancreas development in mice with the inactivation
of oc genes.
In the absence of HNF-6, Oc3 expression in the endoderm,
liver and pancreas is undetectable (Pierreux et al., 2004). This
suggested that the hnf6−/− phenotype may result from
deficient Oc3 expression. Our data on oc3−/− embryos rule
out this hypothesis, since these embryos did not show liver
(data not shown) or pancreatic defects. Also, the liver (data not
shown) and pancreatic phenotypes of hnf6−/−;oc3−/−
embryos were indistinguishable from those of hnf6−/−
embryos. Therefore, the present study does not reveal a
redundancy between HNF-6 and OC-3 during development. In
addition, the absence of OC-3 expression in the hnf6−/−
background and hence in the hnf6−/−;oc2−/− background
(Fig. S4) leads to the conclusion that these double knockoutembryos are in fact triple knockout for the Onecut factors,
since OC-3 is never expressed in their endoderm-derived
organs.
In hnf6−/− embryos, the onset of Pdx-1 expression in the
endoderm is delayed and starts around the 20-somite stage,
indicating that HNF-6 controls pancreas specification. Expres-
sion of Oc3 is undetectable in hnf6−/− embryos, whereas that
of Oc2 in hnf6−/− embryos is normal (Pierreux et al., 2004),
suggesting that OC-2 could compensate partially for the
absence of HNF-6 during pancreas specification. However,
this was not the case since oc2−/− embryos developed a normal
pancreas, and hnf6−/−;oc2−/− and hnf6−/− embryos showed
comparable early pancreatic development. This is consistent
with the timing of OC-2 protein expression. Indeed, while the
Oc2 mRNA is detected starting at the 14-somite stage (Pierreux
et al., 2004), OC-2 protein is not detectable by immunohis-
tochemistry before the 25-somite stage (data not shown).
Therefore, our results suggest that HNF-6 is the only Onecut
protein required for pancreas specification.
In contrast, development of the pancreas at later stages
requires both HNF-6 and OC-2, as differences were observed
between hnf6−/− and hnf6−/−;oc2−/− embryos. In hnf6−/−;
oc2−/− embryos, the size of the dorsal pancreas was more
reduced than in hnf6−/− embryos, indicating that HNF-6 and
OC-2 together contribute to the expansion of the dorsal
pancreas. The ventral pancreas in wild-type embryos derives
from two ventro-lateral buds (Lammert et al., 2001; Tremblay
and Zaret, 2005) which fuse to form a single ventral bud around
e9.5. At e13.5, a single hypoplastic ventral bud was detected in
hnf6−/− embryos, whereas two small ventral clusters of Pdx-1-
positive cells were found in hnf6−/−;oc2−/− embryos (Fig. 3).
We propose that in hnf6−/−;oc2−/− embryos, fusion failed to
occur, giving rise to the two clusters of Pdx-1 cells on the
duodenum.
Our study also reveals a redundant role of Onecut factors in
pancreatic endocrine differentiation. This process was normal in
oc2−/− embryos. In contrast, endocrine differentiation in
hnf6−/− embryos and in hnf6−/−;oc2−/− embryos was
correctly initiated at e9.5, but became defective around e12.5,
as evidenced by reduced expression of Ngn3. In hnf6−/−;oc2−/−
embryos, the deficiency was more severe than in hnf6−/−
embryos, since the number of Ngn3+ cells and of hormone-
producing cells was more reduced in hnf6−/−;oc2−/− embryos
than in hnf6−/− embryos. These data indicate that HNF-6 and
OC-2 exert redundant functions in endocrine differentiation
and are required to maintain the differentiation process of
endocrine precursors. The endocrine defect in hnf6−/−;oc2−/−
embryos did not result from developmental arrest of the
pancreas, since the expression of ductal and exocrine markers
was detectable in these embryos at a stage when endocrine
markers had become nearly undetectable (Fig. S5). Our
finding that OC-2 can bind and stimulate the ngn3 promoter,
in a comparable way to HNF-6 (Jacquemin et al., 2000),
suggest that both Onecut factors are direct stimulators of
Ngn3 in the pancreatic epithelium. An endocrine phenotype
similar to that found in hnf6−/− and in hnf6−/−;oc2−/−
embryos is observed in the prox1−/− embryos (Wang et al.,
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1 in the endocrine differentiation cascade. However, Prox1
expression in the hnf6−/− and hnf6−/−;oc2−/− embryos was
normal (data not shown). It remains to be investigated if Prox-1
could regulate the expression of Onecut factors in the pancreas.
Recently, HNF-6 was shown to be important for pancreatic
duct morphogenesis (Pierreux et al., 2006). This is not the case
for OC-2, as the ductal morphogenesis was not more affected in
the hnf6−/−;oc2−/− pancreas than in hnf6−/− pancreas.
In the present work, we also show that OC-2 and OC-3
delineate specific domains of the developing gastrointestinal
tract. Indeed, around e12.5, OC-3 was found in the developing
gut, from the antral stomach to the region of the duodenum that
connects with the common bile duct. At the same stage, OC-2
was found more caudally in the gut and the anterior limit of its
expression coincided with the posterior limit of OC-3 expres-
sion. Therefore, OC-2 and OC-3 are markers of specific antero-
posterior domains of the developing gut and may participate in
the establishment of the antero-posterior axis of gut develop-
ment. They are however not required, as evidenced by the
apparent lack of intestinal phenotype in oc2−/−, oc3−/− and
oc2−/−;oc3−/− mice.
We also show here that OC-3 is a novel marker of the
enteroendocrine lineage. OC-3 was found in mature, Chro-
moA-expressing cells, but also in ChromoA-negative cells. The
OC-3+/ChromoA− cells most likely define an intermediated
stage during enteroendocrine differentiation, namely between
the Ngn3-positive precursor stage and the mature ChromoA-
positive stage, as evidenced by the absence of OC-3+/
ChromoA− cells in Ngn3−/− embryos. Our data on oc3−/−
mice show that OC-3 is not required for enteroendocrine
differentiation, but its expression profile indicates that it is a
useful marker to characterize enteroendocrine differentiation.
Consequently, our study reveals that upstream regulators of
Ngn3 differ in the pancreas and in the gastrointestinal tract. In
the pancreas, HNF-6 is required for normal expression of
Ngn3, whereas in the gastrointestinal tract Onecut factors are
dispensable for Ngn3 expression.
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